Funder: Johnson & Johnson (Janssen)
Due Dates: August 31, 2026 (Multiple Myeloma Education RFP) | November 13, 2026 (Oncology Nursing Fellowship RFP) | At least six weeks before program start (General submissions)
Funding Amounts: Award amounts are not specified on the program page.
Summary: Supports independent healthcare education and advanced fellowship training to improve patient care and strengthen an inclusive, connected health system.
Key Information: Applicant eligibility and submission requirements depend on the grant category and applicable RFP.
Description
Johnson & Johnson Innovative Medicine supports independent training and education that strengthens healthcare professionals’ knowledge and skills while addressing patient and community needs. The program emphasizes communities facing barriers to equitable healthcare access and representation. Continuing education may serve physicians, nurses, residents, pharmacists, and allied healthcare professionals through live or virtual activities, dinner programs, grand rounds, and on-site engagement with healthcare teams.
The initiative also supports independent fellowships providing advanced clinical, research, and educational training to develop healthcare leaders and improve patient care. Its educational priorities span neuroscience, oncology, and immunology. Topics include diagnosis, treatment selection, emerging therapies, adverse-event management, patient preferences, and coordination between community and academic care. Specific 2026 RFPs address multiple myeloma education and oncology nursing fellowships.
